Patient Education Following a Stroke

Stroke Clinical Trial

— EPIC  

Official title:

Impact of Patient Education Following a Stroke on Knowledge of Risk Factors, Stroke Warning Signs and What to do in Cases of Stroke

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02834273
• Other study ID #: 2013/18
• Status: Completed
• Phase: N/A
• First received: June 20, 2016
• Last updated: November 30, 2017
• Start date: June 2013
• Est. completion date: August 2016

Study information

• Verified date: November 2017
• Source: Hopital Foch
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The rapid diagnosis and treatment of acute ischemic stroke are critical in the reduction of morbidity, disability and stroke associated mortality Under-education about stroke may prevent people from recognizing symptoms early enough to seek immediate care.

The studies reported on stroke patients managed in stroke center have shown that 39-42% of patients could not name any symptoms of stroke and 36% to 43% no risk factor of stroke.

The stroke patients are therefore a population at high risk for neurological events and cardiac vascular recurrence. However, no studies have evaluated the interest of the development of therapeutic workshops in stroke unit to educate patients about symptoms suggestive of stroke, risk factors and what to do in cases of stroke.

Investigators assume that the setting up of a therapeutic education workshop in the stroke unit may allow a better understanding of the symptoms, risk factors and what to do following stroke. So there is a direct benefit to the patient represented by a better knowledge of stroke (warning signs, risk factors, what to do), improved treatment compliance and reduced risk of recurrence.

More generally, there is a real benefit to promote these messages to the public through the patient and his relatives

Recruitment information / eligibility

• Status: Completed
• Enrollment: 199
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients older than 18 years.

• Diagnosis of ischemic stroke;

• Patients with back home or shorter rehabilitation;

• Patients affiliated to a social security scheme;

• Patients who consented to participate in writing.

Exclusion Criteria:

• Patients with cognitive disorders, vigilance, aphasia.

• Patients institutionalized.

Related Conditions & MeSH terms

• Stroke

Intervention

Behavioral:
• stroke education workshops

Locations

Country	Name	City	State
France	Hopital Foch	Suresnes

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Foch

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Questionnaire EPIC score	The questionnaire score will concern knowledge of stroke risk factors, alert symptoms and what to do : 1 point by quoted risk factor, 2 points by quoted symptom and 3 by quoted conduct	3 months
Secondary	Blood pressure		12 months
Secondary	LDL-C		12 months
Secondary	Body Mass Index		12 months
Secondary	Smoking intoxication		12 months
Secondary	Recurrent stroke		12 months
Secondary	Compliance to treatments		12 months